Recently, we demonstrated that a cell-penetrating VDAC1-based peptide, R-Tf-D-LP4, arrested steatosis and the NASH produced by feeding mice a high-fat diet (HFD-32), and reversed liver pathology to a normal-like state [88]. This evidence concerns the gene TF and steatosis.